Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer’s Disease Condition

The lysosomal cysteine protease cathepsin B (CTSB) has been suggested as a biomarker for Alzheimer’s disease (AD) because elevated serum CTSB in AD patients has been found to correlate with cognitive dysfunction. Furthermore, CTSB gene knockout (KO) in non-transgenic and transgenic AD animal models...

Descripción completa

Detalles Bibliográficos
Autores principales: Hook, Gregory, Kindy, Mark, Hook, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185432/
https://www.ncbi.nlm.nih.gov/pubmed/36970896
http://dx.doi.org/10.3233/JAD-221005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185432/
https://www.ncbi.nlm.nih.gov/pubmed/36970896
http://dx.doi.org/10.3233/JAD-221005

Ejemplares similares